Refresh

0 Hits

Altschwager

Der Arzneimittelbegriff im deutschen, europäischen und US-amerikanischen Recht

Nomos,  2016, 386 Pages

ISBN 978-3-8487-2953-1


Our continuation service: You will receive new series titles or new editions automatically and without obligation to purchase. If you wish to do so, you can mark it in the shopping cart.

The work is part of the series Marburger Schriften zum Gesundheitswesen (Volume 28)
99,00 € incl. VAT
Also available as eBook
99,00 € incl. VAT
Available
Add to shopping cart
Add to notepad
 Further options for registered users

englischThe question whether a product is subject to the drug law’s stringent regulatory market access, distribution and advertising regulations hinges on the interpretation of the controversial regulatory drug definition. A particular point of debate is the importance and meaning of the term ‘pharmacological action’, which has been taken over from medical device law into the drug definition.

This work is the first to analyse the drug definition by way of legal comparison to US and FDA law and focuses on the borderline with the medical devices definition. It shows that the drug and device definitions of US law have significantly shaped European law – and, thus, indirectly German drug law, too. On this basis, the work compares the FDA’s policy on classifying products as drugs or devices with the case law of the ECJ and the German courts as well as with the German legal authors, and offers its own classification proposal.